STS Capital Partners
Rob Mayers is a seasoned professional in the life sciences sector, currently serving as Principal and Life Sciences Consultant at Meld Partners since December 2008, where expertise includes biotech consulting and recruitment focused on drug discovery and clinical development in areas such as neuroscience, immunology, oncology, and gene therapy. Additionally, Rob serves as an Advisor at STS Capital Partners, assisting founder-led businesses in securing financial capital. Previous roles encompass Global Account Manager at SmartSearch | APS, Inc., Corporate Recruiter at Dexcom and Alere, and Account Manager at Yoh Scientific, with early career experience as an Operations Associate at Biogen Idec. Rob holds a Bachelor of Science degree in Biological Sciences from UC Santa Barbara.
This person is not in any offices
STS Capital Partners
STS Capital Partners is a global M&A firm specializing in divestitures, mergers, acquisitions, strategic consulting, and financial advisory services for mid-market private businesses. Our mission is to make Extraordinary Exits possible for our clients. With our unique experience and capabilities, we’re able to realize true potential value in three distinct ways: being expert guides along the sales journey; ensuring our clients achieve maximum financial value by selling to strategic buyers; and supporting clients in creating a lasting legacy. Our extensive global relationships, world-class team, and proven deal process bring international strategic buyers and investors to the table. The result is larger, more competitive, multi-bidder soft auctions that deliver maximum financial returns. By generating maximum returns, we’ve helped clients fulfill bigger ambitions in life and leave lasting legacies that make the world a better place. For businesses facing financial challenges, we can help identify solutions that support stability and drive value before embarking on an Extraordinary Exit. Visit www.stscapital.com to start your journey to an Extraordinary Exit.